United States· US:42192-328_49655b7a-d522-d5e1-e063-6394a90a3727
NP Thyroid 120
A medicinal product containing levothyroxine; liothyronine, registered in United States by Acella Pharmaceuticals, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LEVOTHYROXINE; LIOTHYRONINE
- Manufacturer
- Acella Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1142192-328-01
- ndc1142192-328-30
- ndc1142192-328-90
- ndc114219232801100 TABLET in 1 BOTTLE (42192-328-01)
- ndc11421923283030 TABLET in 1 BOTTLE (42192-328-30)
- ndc11421923289090 TABLET in 1 BOTTLE (42192-328-90)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a869efd5-aa1b-406c-b693-4b2e09b19bae GET /v1/drugs/a869efd5-aa1b-406c-b693-4b2e09b19bae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "76; 18",
"substance": "LEVOTHYROXINE; LIOTHYRONINE",
"productndc": "42192-328",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "ug/1; ug/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about levothyroxine; liothyronine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.